hepatitis delta

Gilead trumpets win for the chronic hepatitis delta prospect it acquired in $1B+ buyout
Fierce Pharma
Thu, 06/23/22 - 07:47 pm
Gilead Sciences
hepatitis delta
Hepcludex
Gilead files first hepatitis delta therapy with FDA
Pharmaforum
Mon, 11/22/21 - 10:25 am
Gilead Sciences
buleviritide
antivirals
hepatitis delta
FDA